In vitro renal toxicity and in vivo therapeutic efficacy in experimental murine cryptococcosis of amphotericin B (Fungizone) associated with Intralipid
暂无分享,去创建一个
[1] G. Lopez-Berestein,et al. Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins , 1993, Antimicrobial Agents and Chemotherapy.
[2] O. Casasnovas,et al. Efficacy and tolerance of an amphotericin B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patients. , 1993, The Journal of antimicrobial chemotherapy.
[3] P. Legrand,et al. Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes , 1992, Antimicrobial Agents and Chemotherapy.
[4] J. Barwicz,et al. Effects of the aggregation state of amphotericin B on its toxicity to mice , 1992, Antimicrobial Agents and Chemotherapy.
[5] N. Mocsny. Cryptococcal Meningitis in Patients with AIDS , 1992, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.
[6] P. Moreau,et al. Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with intralipid compared with conventional amphotericin B in neutropenic patients. , 1992, The Journal of antimicrobial chemotherapy.
[7] Claude Carbón,et al. Tissue distribution and antifungal effect of liposomal itraconazole in experimental cryptococcosis and pulmonary aspergillosis. , 1992, The American review of respiratory disease.
[8] J. Bennett,et al. Comparative safety, tolerance, and pharmacokinetics of amphotericin B lipid complex and amphotericin B desoxycholate in healthy male volunteers. , 1991, The Journal of infectious diseases.
[9] Claude Carbón,et al. Limited protection by small unilamellar liposomes against the renal tubular toxicity induced by repeated amphotericin B infusions in rats , 1991, Antimicrobial Agents and Chemotherapy.
[10] F. Heitz,et al. One-sided action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium. , 1991, Biochemistry.
[11] W. R. Campbell,et al. Direct vasoconstriction as a possible cause for amphotericin B-induced nephrotoxicity in rats. , 1991, The Journal of clinical investigation.
[12] R. Diamond,et al. The growing problem of mycoses in patients infected with the human immunodeficiency virus. , 1991, Reviews of infectious diseases.
[13] J. Adler-Moore,et al. Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents. , 1991, The Journal of antimicrobial chemotherapy.
[14] Claude Carbón,et al. Interactions of free and liposomal amphotericin B with renal proximal tubular cells in primary culture. , 1990, The Journal of pharmacology and experimental therapeutics.
[15] L. Chan,et al. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. , 1990, Annals of internal medicine.
[16] G. Lopez-Berestein,et al. Pharmacokinetics, tissue distribution, and toxicity of free and liposomal amphotericin B in diabetic rats. , 1990, The Journal of infectious diseases.
[17] J. Bolard,et al. Affinity of amphotericin B for phosphatidylcholine vesicles as a determinant of the in vitro cellular toxicity of liposomal preparations. , 1990, Biochimica et biophysica acta.
[18] B. Strom,et al. Risk factors for Amphotericin B-associated nephrotoxicity. , 1989, The American journal of medicine.
[19] Aquilur Rahman,et al. Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice , 1989, Antimicrobial Agents and Chemotherapy.
[20] G. Poste,et al. An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis. , 1988, The Journal of infectious diseases.
[21] M. C. Popescu,et al. Unusual lipid structures selectively reduce the toxicity of amphotericin B. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[22] J. Bolard,et al. Circular dichroism for the determination of amphotericin B binding to liposomes. , 1988, Analytical biochemistry.
[23] J. Sculier,et al. Pilot study of amphotericin B entrapped in sonicated liposomes in cancer patients with fungal infections. , 1988, European journal of cancer & clinical oncology.
[24] R. Diasio,et al. Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis. , 1987, The American journal of medicine.
[25] L. Frankel,et al. Treatment of hepatosplenic candidiasis with liposomal-amphotericin B. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] K. Holmberg,et al. Fungal infections in patients with AIDS and AIDS-related complex. , 1986, Scandinavian journal of infectious diseases.
[27] W. Holleran,et al. Empiric amphotericin B therapy in patients with acute leukemia. , 1985, Reviews of infectious diseases.
[28] J. Reuben,et al. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. , 1985, The Journal of infectious diseases.
[29] F. Szoka,et al. Efficacy of liposome-intercalated amphotericin B in the treatment of systemic candidiasis in mice , 1984, Antimicrobial Agents and Chemotherapy.
[30] D. Schlessinger,et al. Interaction of plasma proteins and lipoproteins with amphotericin B. , 1984, The Journal of infectious diseases.
[31] J. Bolard,et al. Antifungal agents useful in therapy of systemic fungal infections. , 1983, Annual review of pharmacology and toxicology.
[32] R. New,et al. Antileishmanial activity of amphotericin and other antifungal agents entrapped in liposomes. , 1981, The Journal of antimicrobial chemotherapy.
[33] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[34] J. Burges,et al. Nephrotoxicity of amphotericin B, with emphasis on changes in tubular function. , 1972, The American journal of medicine.
[35] V. Andriole,et al. An experimental model of amphotericin B nephrotoxicity with renal tubular acidosis. , 1971, The Journal of laboratory and clinical medicine.
[36] W. Butler,et al. AMPHOTERICIN B RENAL TOXICITY IN THE DOG. , 1964, The Journal of pharmacology and experimental therapeutics.